Derms are thinking like rheums now! Dr. April Armstrong noted most derms digging below the surface to assess pts with psoriasis for systemic diseases to help them to choose systemic treatments. @rheumnow #RNL2024 https://t.co/7HTmiA6m4L

EULAR guidelines and GRAPPA guidelines are moving closer to each other in treatment approaches - @AlexisOgdie @rheumnow #RNL2024 https://t.co/wtp57s28Bz

EULAR 2019 PsA treatment guidelines, as detailed in 2023 presented by @AlexisOgdie We are starting to see EULAR and GRAPPA guidelines complimenting each other with the caveat that EULAR tends to focus on oligo vs polyarticular, vs peripheral arthritis terminology in GRAPPA… https://t.co/K8gtI7Makm https://t.co/iK5x8hlIda

Effects of obesity and weight loss in PsA. Very significant benefit, OR of MDA 6.67 for 10%+ weight loss @AlexisOgdie @RheumNow #RNL2024 https://t.co/130KAucPl7

GRAPPA recommendations 2021 Guide therapy by the active domains, filter by co-morbidities @AlexisOgdie @RheumNow #RNL2024 https://t.co/C1RQAM8DrI

Dr. @AlexisOgdie reviews the updated GRAPPA guideline and changes since 2015. #RNL2024 @RheumNow https://t.co/N2HAmlLj83

How to define "severe" disease? Erosions, multi-site involvement, affecting ADLs/QoL - @AlexisOgdie @rheumnow #RNL2024 https://t.co/gc8bSeSTyJ

2018 ACR/National Psoarasis Foundation Guidelines for Treatment of PsA - Created helpful definitions of Severe PsA and Severe PsO #RNL2024 @RheumNow @AlexisOgdie https://t.co/kH4UzlEWxA

Clinical pearl alert! Check out https://t.co/rvkKlJ8mtk. This site can help you with your PsO decision tree and will be updated again this year. @AlexisOgdie also shares her personal decision tree when approaching patient care while emphasizing shared decision making. #RNL2024… https://t.co/GFYjHw2hgF https://t.co/I8xpekFmYk

“TNFi, IL17i, JAKi--- note that these are the only classes of drug that work for axial spondyloarthritis!” – Dr. @AlexisOgdie noted ustekinumab, apremilast, and abatacept do not work for inflammatory back pain. @rheumnow #RLN2024 https://t.co/BHV6qCUdYi

#RNL2024 @RheumNow @AlexisOgdie Many therapies for SpA - but ONLY TNFi, IL17i, and JAKi for AxSpA Check out https://t.co/V7JGc6t72C to help guide treatment decisions: Prior therapies? enthesitis? concomitant IBD/uveitis? comorbidities? Pt preferences? https://t.co/hfFikMs9YL